LAROTRECTINIB

896 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAROTRECTINIB:

# Side effect Count
0 DIZZINESS 62
1 FATIGUE 62
2 DRUG INEFFECTIVE 61
3 DEATH 52
4 NEUROPATHY PERIPHERAL 45
5 PAIN 44
6 DISEASE PROGRESSION 38
7 NAUSEA 38
8 OFF LABEL USE 38
9 MYALGIA 27
See all common reactions for LAROTRECTINIB

LAROTRECTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NTRK GENE FUSION OVEREXPRESSION 1 0.5000
1 NTRK GENE FUSION CANCER 2 0.5000
2 MALIGNANT NEOPLASM OF RETINA 1 0.3333
3 CONGENITAL FIBROSARCOMA 1 0.3333
4 NTRK GENE FUSION POSITIVE 1 0.3333
5 NASAL ASPIRATION 1 0.2500
6 MESOBLASTIC NEPHROMA 1 0.1250
7 FIBROSARCOMA METASTATIC 1 0.0909
8 SALIVARY GLAND CANCER RECURRENT 1 0.0667
9 ADENOCARCINOMA OF SALIVARY GLAND 2 0.0513
See all enriched reactions for LAROTRECTINIB